Navigation Links
Telik Reports Positive Data Demonstrating Synergy in Combination,and Highly Statistically Significant Effect of Telcyta as,Maintenance Therapy in First-Line Non-Small Cell Lung Cancer

cer. A second drug development candidate, TELINTRA(TM) (TLK199), is in clinical development for myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at http://www.telik.com.

This press release contains "forward-looking" statements, including statements regarding the potential for TELCYTA to treat one or more types of cancer. There are important factors that could cause Telik's results to differ materially from those indicated by these forward-looking statements, including, among others, that none of Telik's product candidates have been determined to be safe or effective in humans or been approved for marketing, clinical trials of Telik's product candidates may take several years to complete and may not be successful, success in preclinical testing and early clinical trials does not ensure that later clinical trials will be successful and interim results of clinical trials do not necessarily predict final results. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its annual report on Form 10-K for the year ended December 31, 2006. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELCYTA, TELINTRA and TRAP are trademarks or registered trademarks of Telik, Inc.

CONTACT: Carol D. DeGuzman, Senior Director, Corporate Communications ofTelik, Inc. +1-650-845-7728, cdeguzman@telik.com

Web site: '"/>




Page: 1 2 3 4

Related medicine technology :

1. Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
(Date:4/1/2015)... Pa. , April 1, 2015  Egalet ... integrated specialty pharmaceutical company focused on developing, manufacturing ... pricing of an offering of $60.0 million aggregate ... 2020 (the "notes") in a private placement to ... the Securities Act of 1933, as amended (the ...
(Date:4/1/2015)... April 1, 2015 Valeant ... and TSX: VRX) today announced ... acquisition of Salix Pharmaceuticals, Ltd. Salix ... that offers innovative gastroenterology treatments such ... esterase inhibitor [recombinant]), APRISO ®  (mesalamine), UCERIS ...
(Date:4/1/2015)... 1, 2015  Salix Pharmaceuticals, Ltd. ("Salix"), a ... (NYSE: VRX ) (TSX:VRX), today announced that ... aggregate principal amount of its 6.00% Senior Notes ... Notes ") pursuant to two redemptions. On May ... amount of the Notes, and on May 4, ...
Breaking Medicine Technology:Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3
(Date:4/1/2015)... York, NY (PRWEB) April 01, 2015 ... the newest venues in the United States. The San Francisco ... and while it opened only last year, Levi’s Stadium has ... notable events that have been held here thus far include ... between the Los Angeles Kings and San Jose Sharks, Wrestlemania ...
(Date:4/1/2015)... April 01, 2015 Bird B Gone, ... and residential applications now offers a complete line of ... range of bird netting products quickly, safely and efficiently. ... success of any bird netting installation. It’s important to ... planning stages of a project. This includes deciding whether ...
(Date:4/1/2015)... 01, 2015 Baby Bellies & Beyond ... latest information on the top products and services to ... Guinness World Records title for "Mommy Moments” - the ... 1st annual Baby Bellies & Beyond Expo Orlando on ... Guinness World Record will commence at 11:00am with actual ...
(Date:4/1/2015)... IL, Bethesda, MD, Alexandria, VA (PRWEB) April 01, ... Clinical Pathology (ASCP), the College of American Pathologists ... the American Society of Clinical Oncology (ASCO) today ... on the use of molecular marker testing for ... evidence-based guideline will help establish standard molecular marker ...
(Date:4/1/2015)... 2015 Parents of teenaged and adolescent ... where the latest post discusses Teen Violence Related to ... Teen Dating Violence Awareness Month, the substance abuse treatment ... to help parents identify if there may be problems ... involve drugs or alcohol. , “People learn how to ...
Breaking Medicine News(10 mins):Health News:Levi's® Stadium Tickets for Super Bowl 50, Kenny Chesney & Jason Aldean, One Direction, Taylor Swift and Luke Bryan Available at Discounted Prices at TicketDown.com 2Health News:Levi's® Stadium Tickets for Super Bowl 50, Kenny Chesney & Jason Aldean, One Direction, Taylor Swift and Luke Bryan Available at Discounted Prices at TicketDown.com 3Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2
... Rapid, Secure Exchange of Healthcare Information Will Speed Claims ... -- The Social Security Administration is realizing significant reductions ... support the processing of disability claims through the use ... developed by Harris Corporation (NYSE: HRS ). ...
... 6 (HIMSS,09, Booth #3974) -- Harris ... redesigning the web site "CTisUS" ( www.ctisus.com ... content for radiologic technologists and other allied healthcare professionals ... 100 countries. "CTisUS" was created and is maintained ...
... In a recent survey of ophthalmologists across the ... can enhance the ocular comfort of glaucoma patients, ... enhance patient quality of life. Nine out of ... glaucoma medications available, and nearly half (47%) do ...
... (NYSE: HAE ) announced today that Richard ... April 2, 2009. Mr. Meelia is Chairman, President ... company. He is retiring from Haemonetics, Board in ... Brad Nutter, Chairman of Haemonetics, Board of Directors, said, ...
... cancer-preventing ability, researcher says , , MONDAY, April 6 (HealthDay News) ... to reduce the risk of stomach ulcers and probably stomach ... a long list of malignancies for which studies have shown ... -- including cancer of the esophagus, bladder, skin and lung, ...
... B-to-B and B-to-C Firm Starts with Several Accounts; ... April 6 Feintuch Communications, Inc. ( ... by industry veteran and former journalist Henry Feintuch, ... Park Avenue in New York City.(Logo: ...
Cached Medicine News:Health News:Social Security Administration First to Go Live With CONNECT Solution for Nationwide Health Information Network 2Health News:Harris Corporation Redesigning Popular Radiology Web Site to Enhance Content Management and Accessibility 2Health News:Glaucoma Survey: Half Unaware of Preservative-Free Beta-Blocker, Ophthalmologists Cite Benefits of Preservative-Free Medications on Ocular Comfort and Quality of Life 2Health News:Glaucoma Survey: Half Unaware of Preservative-Free Beta-Blocker, Ophthalmologists Cite Benefits of Preservative-Free Medications on Ocular Comfort and Quality of Life 3Health News:Glaucoma Survey: Half Unaware of Preservative-Free Beta-Blocker, Ophthalmologists Cite Benefits of Preservative-Free Medications on Ocular Comfort and Quality of Life 4Health News:Haemonetics Announces Change to Board of Directors 2Health News:Broccoli May Ward Off Serious Stomach Ailments 2Health News:Broccoli May Ward Off Serious Stomach Ailments 3Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 2Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 3Health News:Feintuch Communications Launches as Independent Strategic Relations Firm 4
Peribulbar Needle, 23 g. Atkinson style bevel. Overall length 31 mm. 5/box....
Blade tip handle....
Full Handle Laseredge Slit Blade Knife, 3.5 mm angled bevel up. Blade tip dimension: 14.7 mm x 3.5 mm x 3.9 mm....
Full Handle Laseredge Slit Blade Knife, 3.0 mm angled bevel up. Blade tip dimension: 14.4 mm x 3.0 mm x 3.7 mm....
Medicine Products: